Loading…
Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A
Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and s...
Saved in:
Published in: | Journal of pharmacy and pharmacology 2020-07, Vol.72 (7), p.927-937 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573 |
---|---|
cites | cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573 |
container_end_page | 937 |
container_issue | 7 |
container_start_page | 927 |
container_title | Journal of pharmacy and pharmacology |
container_volume | 72 |
creator | Chan, Kit Frankish, Neil Zhang, Tao Ece, Abdulilah Cannon, Aoife O'Sullivan, Jacintha Sheridan, Helen |
description | Objectives
PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold.
Methods
Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8).
Key findings
PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells.
Conclusions
The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis. |
doi_str_mv | 10.1111/jphp.13269 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7497186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2410524028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</originalsourceid><addsrcrecordid>eNp9kcFO3DAQhi1UBFvaSx-gstRbpYDtOI7TQyVApQtCYg_t2Zo4NutVEm9tL2hvfYQ-Y58E0w2oXPBlLM2nb2b0I_SBkmOa38lqvVwf05KJZg_NGOGsqGkl36AZIYwVZVWXh-htjCtCSC2EOECHJSsJpYzM0P2Z86CTuzPYjR2MJn7Jn-hulynX5HFaGtxOjEtb7O0E4s4NJkQcTA_JdHhiewMdhjG5v7__uNH2MAyQfNjiwfdGb3qDF3MuTt-hfQt9NO-neoR-Xnz7cT4vrm--X56fXheac9kUApiQHa8sl8BK2zJd11zYFtpScC0aLZu2agW1gnBJOksAJAdbE6qBi3z5Efq686437WA6bcYUoFfr4AYIW-XBqZed0S3Vrb9TNW9qKkUWfJoEwf_amJjUym_CmHdWjFNSMU6YzNTnHaWDjzEY-zyBEvUYknoMSf0LKcMf_9_pGX1KJQN0B9y73mxfUamrxXyxkz4AiZWftg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410524028</pqid></control><display><type>article</type><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><source>Oxford Journals Online</source><creator>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</creator><creatorcontrib>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</creatorcontrib><description>Objectives
PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold.
Methods
Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8).
Key findings
PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells.
Conclusions
The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1111/jphp.13269</identifier><identifier>PMID: 32301120</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Animal models ; Animals ; Anti-Inflammatory Agents - immunology ; Anti-Inflammatory Agents - pharmacology ; Biological activity ; Biological Availability ; Cell Line, Tumor - drug effects ; Cell lines ; Colitis ; cytokine profiling ; Cytokines ; Cytokines - immunology ; Cytotoxicity ; Drug Design ; Humans ; indanes ; Indans - chemistry ; Indans - immunology ; Indans - pharmacology ; Inflammation ; inflammatory bowel disease ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - immunology ; Interferon ; Lipopolysaccharides ; Lipoxygenase ; Macrophages ; Mice ; Molecular Structure ; Nitric oxide ; Research Paper ; Stereochemistry ; Structure-Activity Relationship ; THP-1 Cells - drug effects ; Tumor necrosis factor</subject><ispartof>Journal of pharmacy and pharmacology, 2020-07, Vol.72 (7), p.927-937</ispartof><rights>2020 Royal Pharmaceutical Society</rights><rights>2020 Royal Pharmaceutical Society.</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 The Authors. Journal of Pharmacy and Pharmacology published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</citedby><cites>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</cites><orcidid>0000-0002-9825-7263 ; 0000-0001-8622-9858 ; 0000-0002-7739-5528 ; 0000-0001-5040-9371 ; 0000-0002-9454-752X ; 0000-0002-3087-5145 ; 0000-0003-1079-5364</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32301120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Kit</creatorcontrib><creatorcontrib>Frankish, Neil</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Ece, Abdulilah</creatorcontrib><creatorcontrib>Cannon, Aoife</creatorcontrib><creatorcontrib>O'Sullivan, Jacintha</creatorcontrib><creatorcontrib>Sheridan, Helen</creatorcontrib><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>Objectives
PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold.
Methods
Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8).
Key findings
PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells.
Conclusions
The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</description><subject>Animal models</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - immunology</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Biological activity</subject><subject>Biological Availability</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell lines</subject><subject>Colitis</subject><subject>cytokine profiling</subject><subject>Cytokines</subject><subject>Cytokines - immunology</subject><subject>Cytotoxicity</subject><subject>Drug Design</subject><subject>Humans</subject><subject>indanes</subject><subject>Indans - chemistry</subject><subject>Indans - immunology</subject><subject>Indans - pharmacology</subject><subject>Inflammation</subject><subject>inflammatory bowel disease</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - immunology</subject><subject>Interferon</subject><subject>Lipopolysaccharides</subject><subject>Lipoxygenase</subject><subject>Macrophages</subject><subject>Mice</subject><subject>Molecular Structure</subject><subject>Nitric oxide</subject><subject>Research Paper</subject><subject>Stereochemistry</subject><subject>Structure-Activity Relationship</subject><subject>THP-1 Cells - drug effects</subject><subject>Tumor necrosis factor</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kcFO3DAQhi1UBFvaSx-gstRbpYDtOI7TQyVApQtCYg_t2Zo4NutVEm9tL2hvfYQ-Y58E0w2oXPBlLM2nb2b0I_SBkmOa38lqvVwf05KJZg_NGOGsqGkl36AZIYwVZVWXh-htjCtCSC2EOECHJSsJpYzM0P2Z86CTuzPYjR2MJn7Jn-hulynX5HFaGtxOjEtb7O0E4s4NJkQcTA_JdHhiewMdhjG5v7__uNH2MAyQfNjiwfdGb3qDF3MuTt-hfQt9NO-neoR-Xnz7cT4vrm--X56fXheac9kUApiQHa8sl8BK2zJd11zYFtpScC0aLZu2agW1gnBJOksAJAdbE6qBi3z5Efq686437WA6bcYUoFfr4AYIW-XBqZed0S3Vrb9TNW9qKkUWfJoEwf_amJjUym_CmHdWjFNSMU6YzNTnHaWDjzEY-zyBEvUYknoMSf0LKcMf_9_pGX1KJQN0B9y73mxfUamrxXyxkz4AiZWftg</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Chan, Kit</creator><creator>Frankish, Neil</creator><creator>Zhang, Tao</creator><creator>Ece, Abdulilah</creator><creator>Cannon, Aoife</creator><creator>O'Sullivan, Jacintha</creator><creator>Sheridan, Helen</creator><general>Wiley Subscription Services, Inc</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9825-7263</orcidid><orcidid>https://orcid.org/0000-0001-8622-9858</orcidid><orcidid>https://orcid.org/0000-0002-7739-5528</orcidid><orcidid>https://orcid.org/0000-0001-5040-9371</orcidid><orcidid>https://orcid.org/0000-0002-9454-752X</orcidid><orcidid>https://orcid.org/0000-0002-3087-5145</orcidid><orcidid>https://orcid.org/0000-0003-1079-5364</orcidid></search><sort><creationdate>202007</creationdate><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><author>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - immunology</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Biological activity</topic><topic>Biological Availability</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell lines</topic><topic>Colitis</topic><topic>cytokine profiling</topic><topic>Cytokines</topic><topic>Cytokines - immunology</topic><topic>Cytotoxicity</topic><topic>Drug Design</topic><topic>Humans</topic><topic>indanes</topic><topic>Indans - chemistry</topic><topic>Indans - immunology</topic><topic>Indans - pharmacology</topic><topic>Inflammation</topic><topic>inflammatory bowel disease</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - immunology</topic><topic>Interferon</topic><topic>Lipopolysaccharides</topic><topic>Lipoxygenase</topic><topic>Macrophages</topic><topic>Mice</topic><topic>Molecular Structure</topic><topic>Nitric oxide</topic><topic>Research Paper</topic><topic>Stereochemistry</topic><topic>Structure-Activity Relationship</topic><topic>THP-1 Cells - drug effects</topic><topic>Tumor necrosis factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Kit</creatorcontrib><creatorcontrib>Frankish, Neil</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Ece, Abdulilah</creatorcontrib><creatorcontrib>Cannon, Aoife</creatorcontrib><creatorcontrib>O'Sullivan, Jacintha</creatorcontrib><creatorcontrib>Sheridan, Helen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Kit</au><au>Frankish, Neil</au><au>Zhang, Tao</au><au>Ece, Abdulilah</au><au>Cannon, Aoife</au><au>O'Sullivan, Jacintha</au><au>Sheridan, Helen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>2020-07</date><risdate>2020</risdate><volume>72</volume><issue>7</issue><spage>927</spage><epage>937</epage><pages>927-937</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><abstract>Objectives
PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold.
Methods
Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8).
Key findings
PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells.
Conclusions
The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32301120</pmid><doi>10.1111/jphp.13269</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9825-7263</orcidid><orcidid>https://orcid.org/0000-0001-8622-9858</orcidid><orcidid>https://orcid.org/0000-0002-7739-5528</orcidid><orcidid>https://orcid.org/0000-0001-5040-9371</orcidid><orcidid>https://orcid.org/0000-0002-9454-752X</orcidid><orcidid>https://orcid.org/0000-0002-3087-5145</orcidid><orcidid>https://orcid.org/0000-0003-1079-5364</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3573 |
ispartof | Journal of pharmacy and pharmacology, 2020-07, Vol.72 (7), p.927-937 |
issn | 0022-3573 2042-7158 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7497186 |
source | Oxford Journals Online |
subjects | Animal models Animals Anti-Inflammatory Agents - immunology Anti-Inflammatory Agents - pharmacology Biological activity Biological Availability Cell Line, Tumor - drug effects Cell lines Colitis cytokine profiling Cytokines Cytokines - immunology Cytotoxicity Drug Design Humans indanes Indans - chemistry Indans - immunology Indans - pharmacology Inflammation inflammatory bowel disease Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - immunology Interferon Lipopolysaccharides Lipoxygenase Macrophages Mice Molecular Structure Nitric oxide Research Paper Stereochemistry Structure-Activity Relationship THP-1 Cells - drug effects Tumor necrosis factor |
title | Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioactive%20indanes:%20insight%20into%20the%20bioactivity%20of%20indane%20dimers%20related%20to%20the%20lead%20anti%E2%80%90inflammatory%20molecule%20PH46A&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=Chan,%20Kit&rft.date=2020-07&rft.volume=72&rft.issue=7&rft.spage=927&rft.epage=937&rft.pages=927-937&rft.issn=0022-3573&rft.eissn=2042-7158&rft_id=info:doi/10.1111/jphp.13269&rft_dat=%3Cproquest_pubme%3E2410524028%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410524028&rft_id=info:pmid/32301120&rfr_iscdi=true |